|
FAM48A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.08710000004775E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.210299999998E-05 |
| Normal-vs-Stage2 |
2.422100E-02 |
| Normal-vs-Stage3 |
3.871500E-02 |
| Normal-vs-Stage4 |
7.901900E-02 |
| Stage1-vs-Stage2 |
3.803600E-01 |
| Stage1-vs-Stage3 |
6.587400E-01 |
| Stage1-vs-Stage4 |
3.194400E-01 |
| Stage2-vs-Stage3 |
3.542800E-01 |
| Stage2-vs-Stage4 |
2.344400E-01 |
| Stage3-vs-Stage4 |
7.432000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.90113999999353E-05 |
| Normal-vs-AfricanAmerican |
5.155800E-04 |
| Normal-vs-Asian |
6.184400E-02 |
| Caucasian-vs-AfricanAmerican |
5.274600E-01 |
| Caucasian-vs-Asian |
8.375400E-01 |
| AfricanAmerican-vs-Asian |
7.068800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.69290000001854E-06 |
| Normal-vs-Female |
7.210900E-04 |
| Male-vs-Female |
8.464200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.894350E-02 |
| Normal-vs-Extreme_Weight |
2.663500E-03 |
| Normal-vs-Obese |
1.793140E-04 |
| Normal-vs-Extreme_Obese |
1.173800E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.856400E-01 |
| Normal_Weight-vs-Obese |
2.778600E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.583000E-01 |
| Extreme_Weight-vs-Obese |
1.715620E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.394800E-01 |
| Obese-vs-Extreme_Obese |
3.532800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.503630E-02 |
| Normal-vs-Age(41-60Yrs) |
2.88220000088657E-08 |
| Normal-vs-Age(61-80Yrs) |
1.696330E-03 |
| Normal-vs-Age(81-100Yrs) |
5.422800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.372800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.188200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.250000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.682500E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.130200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.143000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.02080000008442E-08 |
| Normal-VS-Type2 PRCC |
3.702200E-01 |
| Normal-VS-KIRP CIMP |
5.116200E-01 |
| Normal-VS-Unclassified PRCC |
2.021000E-03 |
| Type1 PRCC-VS-Type2 PRCC |
3.23900000043231E-07 |
| Type1 PRCC-VS-KIRP CIMP |
1.441850E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
9.719200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.477600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.158600E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.663220E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.364000E-02 |
| Normal-vs-N1 |
1.309970E-02 |
| Normal-vs-N2 |
4.980400E-01 |
| N0-vs-N1 |
2.677800E-01 |
| N0-vs-N2 |
2.296200E-01 |
| N1-vs-N2 |
1.397610E-01 |
|
|
